Oribase Pharma : innovatives moleculesOriBase Pharma : Proprietary Innovative Technology Platform for Anti-cancer Clinical Candidates DevelopmentOriBase Pharmahttp://www.oribase-pharma.com/enMeet us at BIO-Europe in Dusseldorf<p>OriBase Pharma will be participating in this year&rsquo;s Bio-Europe conference in D&uuml;sseldorf, Germany, October 31st till November 2nd 2011. If you would like to meet us there, feel free to stop by booth number 5.</p>http://www.oribase-pharma.com/news_22/2011/09/24/Meet-us-at-BIO-Europe-in-Dusseldorf_13.htmlhttp://www.oribase-pharma.com/news_22/2011/09/24/Meet-us-at-BIO-Europe-in-Dusseldorf_13.htmlSat, 24 Sep 2011 18:30:00 +0100 Open House Event<p>Monday, April 4th 2011, OriBase Pharma organized a successful Open House event!<br /><br />The program included a presentation of the company, an explanation of R&amp;D projects and our computational chemistry approaches, a roundtable discussion, a visit to our laboratories, and a Lebanese buffet.<br /><br />Several guest speakers came to the event to give a short talk, and we thank them for their support and presence.<br /><br />Jean-Claude Maurel, CEO at Medesis Pharma<br />Cathy Royer, Director of Center for Structural Biochemistry<br />Geraldine KARBOUCH, Director of the Languedoc Roussillon Incubator<br />Julien SAINTE CATHERINE, Responsible for the BIC missions<br />Eric THIEULIN, Legal Adviser in innovation<br /><br />OriBase Pharma will organize a new Open House event later this year.</p>http://www.oribase-pharma.com/news_22/2011/05/24/Open-House-Event_14.htmlhttp://www.oribase-pharma.com/news_22/2011/05/24/Open-House-Event_14.htmlTue, 24 May 2011 01:30:00 +0100 Meet us at BIO-Europe - Hamburg - Germany - November 12-14 2012<p>BIO-Europe<sup>&reg;</sup> is Europe's largest partnering conference, serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. Produced with the support of BIO, it is regarded as a &ldquo;must attend&rdquo; event for the biotech industry</p>http://www.oribase-pharma.com/news_22/2012/11/12/Meet-us-at-BIO-Europe-Hamburg-Germany-November-12-14-2012_15.htmlhttp://www.oribase-pharma.com/news_22/2012/11/12/Meet-us-at-BIO-Europe-Hamburg-Germany-November-12-14-2012_15.htmlMon, 12 Nov 2012 11:30:00 +0100 OriBase Pharma at the Montpellier Marathon 2012<p>The city of Montpelier and its club of athletics, the MAM (Montpelier Athl&eacute;tic M&eacute;diterran&eacute;e) organized the 3rd edition of its Marathon on October 14th, 2012!</p>
<p>A popular and friendly meeting in which the Oribase Pharma team has participated, still taking advantage of pleasant temperature of the autumn.</p>
<p>The race took place entirely in Montpelier thanks to a buckle of 42,195 km serving old and new districts and allowing the Montpellier residents and the spectators to discover a big part of the city. Numerous musical animations had been settled all along the route to accompany the runners in their effort.</p>
<p>We are thus proud to put in the honor in this Newsletter our runners' team!</p>
<p>See photo; from left to right:</p>
<ul>
<li>Gw&eacute;na&euml;l Chev&eacute;: Computational Drug Design Group Leader</li>
<li>Aziz Yasri: CEO of OriBase Pharma.</li>
<li>Arnaud Fauvel: B&eacute;n&eacute;dicte Fauvel's husband, our Senior Project Manager in pharmacology</li>
<li>R&eacute;mi Bois, IT Engineer</li>
<li>Guillaume Cazals: B&eacute;n&eacute;dicte Cazals's husband, our senior Project manager in medicinal Chemistry</li>
</ul>http://www.oribase-pharma.com/news_22/2012/10/18/OriBase-Pharma-at-the-Montpellier-Marathon-2012_16.htmlhttp://www.oribase-pharma.com/news_22/2012/10/18/OriBase-Pharma-at-the-Montpellier-Marathon-2012_16.htmlThu, 18 Oct 2012 11:00:00 +0100 New Headquarters for OriBase Pharma<p>Due to our recent merger in October 2010, between Nova Decision &amp; Azasynth, OriBase Pharma has now moved into new facilities in Biop&ocirc;le Eurom&eacute;decine, Montpellier. These facilities include a new and much bigger laboratory for us to increase our activities, and ensure the possibility for further expansion of our team.<br /> <br />Please register our new company information in your systems: <br /> <br /> <strong>OriBase Pharma</strong><br /> 1682, Rue de la Valsi&egrave;re<br /> Parc Eurom&eacute;decine, Cap Gamma <br /> 34090 Montpellier - France<br /><br /> <strong>Phone:&nbsp; +33 (0)4 67 727 670</strong><br /><strong> Fax: +33 (0)4 67 727 679</strong><br /><br /> TVA: FR07 499 824 670<br /> SIRET: 499 824 670 000 32</p>
<p>All ordering processes will remain unchanged, and all contacts remain the same !</p>http://www.oribase-pharma.com/news_22/2011/01/10/New-Headquarters-for-OriBase-Pharma_17.htmlhttp://www.oribase-pharma.com/news_22/2011/01/10/New-Headquarters-for-OriBase-Pharma_17.htmlMon, 10 Jan 2011 09:45:00 +0100 OriBase Pharma is entitled to taxes return for investment<p>Thanks to a first round of fund raising realized successfully ( 1 500 000&euro;), involving 52 investors, we were able to advance our programs significantly.</p>
<p>We so wish to enter the regulatory preclinical phase , preliminary and critical phase before tests on patients. Once this finished phase ( 2015-2016 ), we shall already have good guarantees that our 2 programs can be acquired by big pharmaceutical groups, having the means to offer not only a return on investment but also to lead the development project until its term.</p>
<p>&nbsp;</p>
<p><span style="font-size: 1.25em;"><strong>- Next Fund raising round: juin </strong><strong>15<sup>th</sup> </strong><strong>2013</strong></span></p>
<p><span style="font-size: 1.25em;"> <strong>- Investment deadline: June 10<sup>th</sup> 2013</strong></span></p>http://www.oribase-pharma.com/news_22/2013/04/25/OriBase-Pharma-is-entitled-to-taxes-return-for-investment_22.htmlhttp://www.oribase-pharma.com/news_22/2013/04/25/OriBase-Pharma-is-entitled-to-taxes-return-for-investment_22.htmlThu, 25 Apr 2013 12:45:00 +0100 OriBae Pharma participated to BioSpain Conference - BioPartnering<p><span class="transpan"><span id="tran0" style="background-color: white;">OriBase Pharma participated in the international fair of BioPartnering Biotech-Pharma which took place on September 19-21st, 2012 in Bilbao -Spain. On this occasion, oriBase Pharma presented its two R&amp;D programs of anticancer molecules (cancers of the liver and the pancreas).</span></span></p>http://www.oribase-pharma.com/news_22/2012/09/19/OriBae-Pharma-participated-to-BioSpain-Conference-BioPartnering_19.htmlhttp://www.oribase-pharma.com/news_22/2012/09/19/OriBae-Pharma-participated-to-BioSpain-Conference-BioPartnering_19.htmlWed, 19 Sep 2012 08:45:00 +0100 OriBase Pharma is selected to present at BioTrinity 2013 Conference ( (Newbury 14-16 May 2013)<p><strong>BioTrinity</strong> is <em>the</em>&nbsp;premier European Biopartnering and Investment Conference, partnering R&amp;D companies with<strong> big pharma</strong> and more <strong>biomedical investors</strong> than<em> any other</em> European partnering conference.&nbsp; 80 investment firms are expected and 90&nbsp;companies will be presenting in the showcase. OriBase Pharma has been selected to present its R&amp;D projects at this largest annual biopartnering meeting in Europe.</p>
<p>&nbsp;</p>
<p>We will be presenting in the Company Showcase at BioTrinity in Newbury on the 14-16th May 2013. If you would like to arrange a meeting with us, please request a meeting with us via the partnering system by registering at <a href="http://www.biotrinity.com">www.biotrinity.com.</a></p>http://www.oribase-pharma.com/news_22/2013/04/10/OriBase-Pharma-is-selected-to-present-at-BioTrinity-2013-Conference-Newbury-14-16-May-2013_21.htmlhttp://www.oribase-pharma.com/news_22/2013/04/10/OriBase-Pharma-is-selected-to-present-at-BioTrinity-2013-Conference-Newbury-14-16-May-2013_21.htmlWed, 10 Apr 2013 07:30:00 +0100